- November 25, 2019 | BY
Phazolicin or PHZ, the newly discovered ribosome-disrupting compound. Why this is a big deal
- November 22, 2019 | BY
Also: studying immune response to malaria; effect of the gut on stroke recover
- November 20, 2019 | BY
Renewed interest in a “failed” drug and a rookie treatment debuts in China
- November 15, 2019 | BY
CDC report finds 3 million people infected annually with superbugs, Also, how astronaut exercises might benefit cancer patients, and climate reports reveal dire forecasts.
- November 14, 2019 | BY
The past influences the present……. and the future holds great promise
- November 13, 2019 | BY
An evolution in new therapeutic strategy that is helping us target deadly rare diseases
- November 12, 2019 | BY
Five key factors that should be considered and evaluated to create a smooth and safe shipping process for study materials
- November 11, 2019 | BY
Better tools and less invasive surgeries. A Q&A with Rush Medical Center neurosurgeon Richard Fessler.
- November 8, 2019 | BY
Also: measles is a wrecking ball, wiping out the immune system’s memory, and can CRISPR-based cancer therapies look promising.
- November 7, 2019 | BY
Friday was just One Day – but a great day, a fabulous day to give back to the community